Abstract
Since 1938, electroconvulsive therapy (ECT) has been widely used in the treatment of catatonia, treatment-resistant depression, and severe mania. According to the American Academy of Child and Adolescent Psychiatry (AACAP), criteria1 for its use in youth is: 1) Presence of severe major depression or mania, schizoaffective disorder, schizophrenia, catatonia, and neuroleptic malignant syndrome. 2) Presence of severe, persistent, and disabling symptoms, such as refusal to eat or drink, severe suicidal ideation, uncontrollable mania, and psychosis. 3) Failure to respond to two adequate trials of medications. 4) ECT can also be used earlier when adequate medication trials cannot be administered because of failure to tolerate pharmacological treatment, or if the patient is incapacitated to the point that he/she is unable to take medication or awaiting a response to a medication poses a grave threat to life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.